Home › Carcinoma a cellule squamose della testa e del collo › New York › Queens
Studi clinici su Carcinoma a cellule squamose della testa e del collo a Queens, NY
20 studi su Carcinoma a cellule squamose della testa e del collo cercano partecipanti presso sedi a Queens e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
In reclutamentoFase 3
- Northwell Health Physicians Partners Radiation Medicine at Queens, Forest Hills · a 3 mi di distanza
- Queens Cancer Center, Rego Park · a 3 mi di distanza
- Northwell Health/Center for Advanced Medicine, Lake Success · a 9 mi di distanza
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
In reclutamentoFase 3
- Memorial Sloan Kettering Nassau, Uniondale · a 13 mi di distanza
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
In reclutamentoFase 3
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · a 11 mi di distanza
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
In reclutamentoFase 2
- NYU Langone Hospital - Long Island, Mineola · a 11 mi di distanza
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
In reclutamentoFase 2
- Memorial Sloan Kettering Nassau, Uniondale · a 13 mi di distanza
A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
In reclutamentoFase 1/2
- START New York, Lake Success · a 9 mi di distanza
Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence
In reclutamentoFase 2
- Perlmutter Cancer Center at NYU Langone Health, Mineola · a 11 mi di distanza
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
In reclutamentoFase 2
- Long Island Jewish Medical Center, New Hyde Park · a 9 mi di distanza
- Northwell Health/Center for Advanced Medicine, Lake Success · a 9 mi di distanza
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
In reclutamentoFase 1
- Site 107 - START New York - Long Island, Lake Success · a 9 mi di distanza
A Study of IDP-001 in Advanced or Metastatic Solid Tumors
In reclutamentoFase 1/2
- START New York Long Island, Lake Success · a 9 mi di distanza
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
In reclutamentoFase 2/3
- NYU Langone Hospital - Long Island, Mineola · a 11 mi di distanza
- Memorial Sloan Kettering Nassau, Uniondale · a 13 mi di distanza
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
In reclutamentoFase 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · a 13 mi di distanza
A Study of MGC026 in Participants With Advanced Solid Tumors
In reclutamentoFase 1
- START-New York Long Island, Lake Success · a 9 mi di distanza
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
In reclutamentoFase 1/2
- Clinical Research Alliance, Inc, Westbury · a 14 mi di distanza
A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer
In reclutamentoFase 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · a 10 mi di distanza
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
In reclutamentoFase 1
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New Hyde Park · a 9 mi di distanza
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon · a 27 mi di distanza
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
In reclutamentoFase 1
- START New York Long Island, LLC, Lake Success · a 9 mi di distanza
A Study of Radiation Therapy After Surgery in People With Oral Tongue Squamous Cell Carcinoma
In reclutamentoFase 2
- Memorial Sloan Kettering Nassau, Uniondale · a 13 mi di distanza
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
In reclutamentoFase 3
- Northwell Health Cancer Institute, Lake Success · a 9 mi di distanza
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
In reclutamentoFase 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · a 13 mi di distanza
Studi su Carcinoma a cellule squamose della testa e del collo in altre città
- Houston, TX47 studi
- Los Angeles, CA42 studi
- Boston, MA40 studi
- New York City, NY39 studi
- Nashville, TN39 studi
- St. Louis, MO28 studi
- Arlington, VA26 studi
- Philadelphia, PA26 studi
- Chicago, IL26 studi
- Atlanta, GA24 studi
- San Antonio, TX22 studi
- New Haven, CT22 studi
Altri studi a Queens
- Cancro al seno64 studi
- Cancro del polmone non a piccole cellule49 studi
- Cancro colorettale31 studi
- Cancro metastatico28 studi
- Cancro ovarico28 studi
- Cancro alla prostata27 studi
- Cancro (tutti i tipi)26 studi
- Cancro dell'endometrio25 studi
- Cancro ai polmoni22 studi
- Leucemia mieloide acuta21 studi
- Mieloma multiplo20 studi
- Cancro pancreatico20 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.